These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11519153)

  • 1. [Reversible inhibitor of MAO-A(RIMA)].
    Inoue T; Koyama T
    Nihon Rinsho; 2001 Aug; 59(8):1530-4. PubMed ID: 11519153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of MAO inhibitors: safety and future.
    Yamada M; Yasuhara H
    Neurotoxicology; 2004 Jan; 25(1-2):215-21. PubMed ID: 14697896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RIMA: a safe concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.
    Nair NP; Ahmed SK; Kin NM
    J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M; Guelfi JD
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase inhibitors and anesthesia: an updated literature review.
    Blom-Peters L; Lamy M
    Acta Anaesthesiol Belg; 1993; 44(2):57-60. PubMed ID: 8237297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release.
    Finberg JP
    Pharmacol Ther; 2014 Aug; 143(2):133-52. PubMed ID: 24607445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibitors.
    Lippmann S
    Am Fam Physician; 1986 Jul; 34(1):113-9. PubMed ID: 3728254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory monoamine oxidases of the new generation].
    Nowakowska E; Chodera A
    Pol Merkur Lekarski; 1997 Jul; 3(13):1-4. PubMed ID: 9432289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moclobemide in patients with dementia and depression.
    Amrein R; Martin JR; Cameron AM
    Adv Neurol; 1999; 80():509-19. PubMed ID: 10410765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry and pharmacology of moclobemide, a prototype RIMA.
    Haefely W; Burkard WP; Cesura AM; Kettler R; Lorez HP; Martin JR; Richards JG; Scherschlicht R; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S6-14. PubMed ID: 1546143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.
    Deftereos SN; Dodou E; Andronis C; Persidis A
    Expert Rev Clin Pharmacol; 2012 Jul; 5(4):413-25. PubMed ID: 22943121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase. Its inhibition.
    Youdim MB
    Mod Probl Pharmacopsychiatry; 1975; 10():65-88. PubMed ID: 1101049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression.
    Weinstock M; Poltyrev T; Bejar C; Youdim MB
    Psychopharmacology (Berl); 2002 Mar; 160(3):318-24. PubMed ID: 11889501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of moclobemide, a new generation reversible Mao-A inhibitor, in a novel animal model of depression.
    Moreau JL; Jenck F; Martin JR; Mortas P; Haefely W
    Pharmacopsychiatry; 1993 Jan; 26(1):30-3. PubMed ID: 8378409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of stress-induced deficit in aggression by monoamine oxidase inhibitors.
    Ossowska G; Klenk-Majewska B; Danilczuk Z; Wróbel A; Zebrowska-Lupina I
    Pol J Pharmacol; 1999; 51(5):391-7. PubMed ID: 10817539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FA-70, a novel selective and irreversible monoamine oxidase-A inhibitor: effect on monoamine metabolism in mouse cerebral cortex.
    Morón JA; Pérez V; Pastó M; Lizcano JM; Unzeta M
    J Pharmacol Exp Ther; 2000 Feb; 292(2):788-94. PubMed ID: 10640319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brofaromine--a selective, reversible, and short-acting MAO-A inhibitor: review of the pharmacological and clinical findings.
    Möller HJ; Wendt G; Waldmeier P
    Pharmacopsychiatry; 1991 Mar; 24(2):50-4. PubMed ID: 1852792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.